Homepage / Technology / Doctors say this start-up could revolutionize how we fight infectious diseases
Amazon says this Prime Day was its biggest shopping event ever Kudlow says President Trump is 'so dissatisfied' with China trade talks that he is keeping the pressure on As stocks regain their footing, an ominous warning looms Goldman Sachs downgrades Clorox to sell, says valuation is 'unsustainably high' How Satya Nadella has spurred a tripling of Microsoft's stock price in just over four years Kudlow says economic growth could top 4% for 'a quarter or two,' more tax cuts could be coming The one chart that explains Netflix’s stunning comeback US housing starts plunge 12% in June to a nine-month low Aerospace titans Boeing and Airbus top $110 billion in orders at Farnborough Target uses Prime Day to its advantage, logging its 'biggest online shopping day' so far this year Billionaire Marc Lasry sees bitcoin reaching up to $40,000 as it becomes more mainstream and easier to trade These are the 10 US airports where you're most likely to be hacked Amazon shares slightly higher as investors await Prime Day results Wreck of Russian warship found, believed to hold gold worth $130 billion A bullish ‘phenomenon’ in bond market is weeks away from fading, top credit strategist says Stocks making the biggest moves premarket: MS, GOOGL, TXN, UAL, NFLX & more Twitter shares up 50% since late April means most upside priced in, analyst says in downgrade EU fines Google $5 billion over Android antitrust abuse Mortgage applications fall 2.5% as buyers struggle to find affordable homes America may not have the tools to counter the next financial crisis, warn Bernanke, Geithner and Paulson Investors are getting spooked as the risk of a no-deal Brexit rises EU expected to fine Google $5 billion over Android antitrust abuse Ex-FBI chief James Comey urges Americans to vote for Democrats in midterm elections Elon Musk apologizes to British cave diver following baseless 'pedo guy' claim Disney, Comcast and Fox: All you need to know about one of the biggest media battles ever Xiaomi shares notch new high after Hong Kong, mainland China stock exchanges reach agreement The trade war is complicating China's efforts to fix its economy European markets set for a strong open amid earnings; Google in focus Hedge fund billionaire Einhorn places sixth in major poker tournament The biggest spender of political ads on Facebook? President Trump Asian stocks poised to gain after Fed's Powell gives upbeat comments; dollar firmer Stocks are setting up to break to new highs Not all FAANG stocks are created equal EU ruling may be too little, too late to stop Google's mobile dominance Cramer explains how Netflix's stock managed to taper its drop after disappointing on earnings Airbnb condemns New York City's 'bellhop politics,' threatens legal retaliation Amazon sellers say they were unfairly suspended right before Prime Day, and now have two bad choices Investor explains why 'duller' tech stocks can have better returns than 'high-flying' tech names Elon Musk is 'thin-skinned and short-tempered,' says tech VC Texas Instruments CEO Brian Crutcher resigns for violating code of conduct Google Cloud Platform fixes issues that took down Spotify, Snapchat and other popular sites Uber exec: We want to become the 'one stop' transportation app 'What a dumb hearing,' says Democrat as Congress grills tech companies on conservative bias Amazon shares rebound, report says Prime Day sales jumped 89 percent in first 12 hours of the event How to put your medical history on your iPhone in less than 5 minutes Investment chief: Watch these two big events in 2018 Even with Netflix slowing, the market rally is likely not over Cramer: Netflix subscriber weakness debunks the 'sky's the limit' theory on the stock Netflix is looking at watch time as a new area of growth, but the competition is stiff Why Nobel laureate Richard Thaler follows Warren Buffett's advice to avoid bitcoin Rolls-Royce is developing tiny 'cockroach' robots to crawl in and fix airplane engines After Netflix plunge, Wall Street analysts forecast just tame returns ahead for the once high-flying FANG group Roku shares rise after analyst raises streaming video company's price target due to customer growth China is investing 9 times more into Europe than into North America, report reveals Amazon says US Prime Day sales 'so far bigger than ever' as glitch is resolved Netflix is on pace for its worst day in two years US lumber producers see huge opportunity, rush to expand San Francisco to consider tax on companies to help homeless Homebuilder sentiment, still high, stalls as tariffs, labor and land drive up costs Powell backs more rate hikes as economy growing 'considerably stronger' Netflix history is filled with big stock declines – like today – followed by bigger rebounds Intel shares get downgraded by Evercore ISI due to rising competition from Nvidia, AMD Petco aims to reinvent the pet store with something you can't buy online Genetic testing is coming of age, but for consumers it's buyer beware Tech 'FAANG' was the most-crowded trade in the world heading into the Netflix implosion, survey shows Netflix weak subscriber growth may indicate a 'maturity wall' that could whack the stock even more: Analyst This chart may be predicting the bull market's demise Wall Street says Netflix's stock plunge is a ‘compelling’ buying opportunity because the streaming giant ‘never misses twice’ Tesla sinks after Musk tweets, again Boeing announces new division devoted to flying taxis Stocks making the biggest move premarket: NFLX, UNH, GS, AMZN, WMT & more Deutsche Bank downgrades Netflix, but says big subscriber miss is not 'thesis changing' IBM is experimenting with a cryptocurrency that’s pegged to the US dollar North Korea and Zimbabwe: A friendship explained Virgin Galactic spinoff Orbit to launch rockets from the UK with space deal Artificial intelligence will create more jobs than it destroys? That’s what PwC says ‘Treasonous’ Trump and ‘Putin’s poodle:' Scathing headlines follow the Trump-Putin summit China’s fintech companies offer ‘enormous’ opportunity, investment manager says Trump's performance at summit with Putin was 'unprecedented,' experts say Walmart and Microsoft link up on cloud technology as they both battle Amazon European stocks seen mixed amid earnings; Fed’s Powell to address Congress How I knew I should quit my day job and run my start-up full-time: Viral website founder China's stocks have been trounced, but the trade war may ultimately be good news for those shares Billionaire tech investor Peter Thiel bets on crypto start-up Block.one Asian shares subdued open after mixed close on Wall Street; energy stocks under pressure Amazon cloud hits snags after Amazon Prime Day downtime Netflix isn't doomed by one quarter unless people start questioning the long-term investor thesis Tech stocks set to sink on Tuesday after rough evening for ‘FANG’ Netflix plummets after missing big on subscriber growth This wristband lets humans control machines with their minds The U.S. has a rocky history convincing Russia to extradite computer criminals Amazon suffers glitches at the start of Prime Day Jeff Bezos is now the richest man in modern history 'The United States has been foolish': Read Trump and Putin's full exchange Goldman Sachs recommends these 5 highly profitable companies — including Nvidia — to combat rising inflation Goldman Sachs releases 'tactical' stock picks for this earnings season Three red flags for Netflix ahead of its earnings report The bond market may be raising recession fears, but don't expect one anytime soon Cramer: Banks are 'making fortunes' but are still as hated as they were during the financial crisis Putin told Trump at summit: Russia never meddled in US election

Technology

Doctors say this start-up could revolutionize how we fight infectious diseases

A three-year-old child in the Bay Area was recently admitted to the hospital with a rash. The child was sent home with a diagnosis of hand-foot-and-mouth disease, a common virus that typically resolves in a few weeks.

But the patient continued to get worse and had to be admitted to the hospital. The doctors were stumped, as more and more tests came back negative.

So they called up a stealthy biotechnology start-up in the Bay Area with a novel technology for detecting disease.

Overnight, the company’s lab got a delivery of the child’s blood. Its technology, which can detect the source of an infection — viral, bacterial or fungal — by analyzing fragments of DNA in the patient’s bloodstream, was able to produce a diagnosis in a business day.

Rat-bite fever.

The child had been scratched, likely by a pet rat.

That company, called Karius, is announcing $50 million in financing from investors including Khosla Ventures, Tencent, and Eric Schmidt’s Innovation Endeavors.

This particular patient was involved in one of its early clinical studies, which intended to compare its test to the current gold standard for infectious disease diagnostics. Karius presented its data at a medical conference in June.

The company’s CEO Mickey Kertesz said the U.S. Centers for Disease Control and Prevention delivered the same result of rat bite fever, but it took several months. That’s because current techniques are hypothesis-driven: A physician has an idea for the culprit, takes a sample to culture, and waits for a positive or negative result. If it’s a negative, they move on to the next idea.

This approach has resulted in patients being treated with antibiotics that they do not need and getting misdiagnosed, said Peter Chin-Hong, a doctor who treats patients with infectious diseases at UC San Francisco. That can often lead to patients getting sicker, or ending up with antibiotic resistance.

Kertesz said the company has figured out a way to separate out the disease-causing agent from bacteria that live harmoniously in the body. “We all have gut and skin bacteria that is found in lower levels when you’re healthy,” he said. “It’s different when you’re sick.”

The company’s test doesn’t cover all infections, but it can detect more than 1,000, including rat-bite fever, valley fever and streptococcal infections.

The test is currently available for $2,000, which costs more than traditional diagnostic tests. For that reason, Karius isn’t positioning its test as a first line of defense for doctors. Rather, it’s for those tricky cases where the patient is critically ill, and the first results come back negative.

About 50 percent of cases result in a definitive diagnosis, said Kertesz. Sometimes, it’s not an infection that is making the patient sick, or the infection has already passed and is no longer detectable in the blood.

Karius has tested thousands of patients in clinical studies thus far. It is planning to launch to clinical practices nationwide later this year.

Doctors who have used Karius’ technology say it could be the future for infectious disease diagnostics and treatment.

“I think this technology will revolutionize medicine,” said Chin-Hong.

“People don’t realize that it’s (medicine) an imprecise science and we use a lot of antibiotics to get one infection that we can’t see,” he added.

Chin-Hong said Karius’ test was able to accurately diagnose a patient getting treated for leukemia with a sexually transmitted infection that was wreaking havoc on their health. Getting an answer early can save lives, he said, especially in cases where the patient’s immune system is compromised.

It will be some time before Karius’ test is used in routine medical care. Currently, it is focused on critically ill patients, including those who are recovering from organ transplants or chemotherapy, or infants that don’t have the blood volume for a round of tests.

The company is hoping that it will treat chronically ill patients next. Millions of people are misdiagnosed every year, which presents another opportunity for Karius’ test.

The company is also looking at other sample types beyond blood to broaden its range of detectable infections, as well as generating resistance profiles to better understand whether a patient will respond to a course of therapy.

One dream for the company is to coin new infectious diseases, as it is already finding signals from unknown microbes. It also sees an opportunity to work with public health researchers to track outbreaks.

For Chin-Hong, the current technology already has promise, as it offers more targeted treatment than the status quo.

“It means one blood draw instead of a series of pokes and sticks for the patient,” he said. “And it means one drug rather than a lot of antibiotics that aren’t needed.”

Source: Tech CNBC
Doctors say this start-up could revolutionize how we fight infectious diseases

Comments are closed.